Company · CIK 2023311

# ASCENTAGE PHARMA GROUP INTERNATIONAL

| CIK | [2023311](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002023311) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Listed | AAPG (Nasdaq) |
| First annual or quarterly report | 2025-04-16 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-284064 | IPO Final prospectus | 2024-12-27 | 2025-01-24 | 4 |

## Filings

 5

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-01-24 | [424B4](https://www.sec.gov/Archives/edgar/data/2023311/000110465925006029/0001104659-25-006029-index.htm) Final prospectus | 333-284064 | 0001104659-25-006029 |
| 2025-01-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2023311/999999999525000168/9999999995-25-000168-index.htm) Declared effective | 333-284064 | 9999999995-25-000168 |
| 2025-01-21 | [F-1/A](https://www.sec.gov/Archives/edgar/data/2023311/000110465925004650/0001104659-25-004650-index.htm) Amendment | 333-284064 | 0001104659-25-004650 |
| 2024-12-27 | [F-1](https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/0001104659-24-132177-index.htm) Registration filed | 333-284064 | 0001104659-24-132177 |
| 2024-06-14 | [DRS](https://www.sec.gov/Archives/edgar/data/2023311/000110465924071459/0001104659-24-071459-index.htm) Draft made public | 377-07274 | 0001104659-24-071459 |

[All filings of this company](https://equitycapital.markets/filings?cik=2023311) · [CSV](https://equitycapital.markets/filings.csv?cik=2023311)

---
Source page: https://equitycapital.markets/company/2023311 · Data: U.S. SEC EDGAR · CC BY 4.0